Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Early and late preterm delivery rates - a comparison of differing tocolytic policies in a single urban population.

Hehir MP, O'Connor HD, Kent EM, Robson MS, Keane DP, Geary MP, Malone FD.

J Matern Fetal Neonatal Med. 2012 Nov;25(11):2234-6. doi: 10.3109/14767058.2012.684171. Epub 2012 May 11.

PMID:
22524700
2.

Tocolytic therapy for acute preterm labor.

Abramovici A, Cantu J, Jenkins SM.

Obstet Gynecol Clin North Am. 2012 Mar;39(1):77-87. doi: 10.1016/j.ogc.2011.12.003. Epub 2012 Jan 4. Review.

PMID:
22370109
3.

Preterm labor: current tocolytic options for the treatment of preterm labor.

Jørgensen JS, Weile LK, Lamont RF.

Expert Opin Pharmacother. 2014 Apr;15(5):585-8. doi: 10.1517/14656566.2014.880110. Epub 2014 Jan 24.

PMID:
24456411
4.

[Atosiban treatment for preterm labor--financial considerations and savings by implementing clinical guidelines].

Hadar E, Mansur N, Ambar I, Hod M.

Harefuah. 2011 Jun;150(6):502-6, 553. Hebrew.

PMID:
21800486
5.

Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.

French/Australian Atosiban Investigators Group.

Eur J Obstet Gynecol Reprod Biol. 2001 Oct;98(2):177-85.

PMID:
11574128
6.

Preterm labor: current pharmacotherapy options for tocolysis.

van Vliet EO, Boormans EM, de Lange TS, Mol BW, Oudijk MA.

Expert Opin Pharmacother. 2014 Apr;15(6):787-97. doi: 10.1517/14656566.2014.889684. Epub 2014 Feb 17. Review.

PMID:
24533566
7.

Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial.

Rozenberg P, Chauveaud A, Deruelle P, Capelle M, Winer N, Desbrière R, Perrotin F, Bohec C, Connan L, Vayssière C, Langer B, Mantel A, Azimi S, Porcher R, Azria E; Groupe De Recherche En Obstétrique et Gynécologie.

Am J Obstet Gynecol. 2012 Mar;206(3):206.e1-9. doi: 10.1016/j.ajog.2011.12.026. Epub 2011 Dec 27.

PMID:
22381603
8.

Maternal admission characteristics as risk factors for preterm birth.

Papatsonis DN, van Geijn HP, Bleker OP, Ader HJ, Dekker GA.

Eur J Obstet Gynecol Reprod Biol. 2004 Jan 15;112(1):43-8.

PMID:
14687737
9.

Vaginal progesterone after tocolytic therapy in threatened preterm labor.

Bomba-Opon DA, Kosinska-Kaczynska K, Kosinski P, Wegrzyn P, Kaczynski B, Wielgos M.

J Matern Fetal Neonatal Med. 2012 Jul;25(7):1156-9. doi: 10.3109/14767058.2011.629014. Epub 2012 Apr 3.

PMID:
21967664
10.

Tocolysis of preterm contractions does not improve preterm delivery rate or perinatal outcomes.

Sciscione AC, Stamilio DM, Manley JS, Shlossman PA, Gorman RT, Colmorgen GH.

Am J Perinatol. 1998 Mar;15(3):177-81.

PMID:
9572373
11.
12.

Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial).

van Vliet EO, Schuit E, Heida KY, Opmeer BC, Kok M, Gyselaers W, Porath MM, Woiski M, Bax CJ, Bloemenkamp KW, Scheepers HC, Jaquemyn Y, van Beek E, Duvekot HJ, Franssen MT, Bijvank BN, Kok JH, Franx A, Mol BW, Oudijk MA.

BMC Pregnancy Childbirth. 2014 Mar 3;14:93. doi: 10.1186/1471-2393-14-93.

13.

Management of recurrent preterm labor in twin gestations with nifedipine tocolysis.

de la Torre L, Istwan NB, Desch C, Rhea DJ, Roca L, Stanziano GJ, González-Quintero VH.

Am J Perinatol. 2008 Oct;25(9):555-60. doi: 10.1055/s-0028-1085622. Epub 2008 Sep 4.

PMID:
18773381
14.

Maximum possible impact of tocolytics in preventing preterm birth: a retrospective assessment.

Menticoglou SM, Morrison I, Harman CR, Manning FA, Lange IR.

Am J Perinatol. 1992 Sep-Nov;9(5-6):394-7.

PMID:
1418142
15.

[Update on current care guidelines: preterm birth].

[No authors listed]

Duodecim. 2011;127(6):570-1. Finnish.

PMID:
21528522
16.
17.

[Tocolysis: indications and contraindications. When to start and when to stop].

D'ercole C, Bretelle F, Shojai R, Desbriere R, Boubli L.

J Gynecol Obstet Biol Reprod (Paris). 2002 Nov;31(7 Suppl):5S84-95. Review. French.

18.

Subcutaneous tocolytic infusion therapy for patients at very high risk for preterm birth.

Allbert JR, Wise CA, Lou CH, Gookin KS, Parmenter MA, Morrison JC.

J Perinatol. 1992 Mar;12(1):28-31.

PMID:
1348530
19.

Neonatal mortality and morbidity rates in late preterm births compared with births at term.

McIntire DD, Leveno KJ.

Obstet Gynecol. 2008 Jan;111(1):35-41. doi: 10.1097/01.AOG.0000297311.33046.73.

PMID:
18165390
20.

Use of atosiban in a twin pregnancy with extremely preterm premature rupture in the membrane of one twin: a case report and literature review.

Wu MY, Chen SU, Lee CN, Ho HN, Yang YS.

Taiwan J Obstet Gynecol. 2010 Dec;49(4):495-9. doi: 10.1016/S1028-4559(10)60103-9. Review.

Supplemental Content

Support Center